Last updated: April 23, 2026
Who Supplies EVEKEO (amphetamine sulfate) in the US?
No complete, accurate supplier map (finished dosage manufacturer, API maker, and authorized secondary suppliers) can be produced from the information available in this chat alone.
What counts as a “supplier” for EVEKEO in a patent/R&D diligence context?
A supplier set for a branded oral drug typically includes at least these parties in the US supply chain:
- Finished dosage manufacturer (drug product) for EVEKEO tablets
- Active pharmaceutical ingredient (API) supplier for amphetamine sulfate
- Primary packager / labeler (often the same entity as the finished-dose manufacturer)
- Authorized distributors listed in commercial channels (if disclosed)
Without verified source-level identification for EVEKEO’s labeled manufacturer(s) and API provenance, any named supplier list would be incomplete or inaccurate.
What can be asserted from the drug name alone?
“EVEKEO” identifies a branded product containing amphetamine sulfate, but the brand name alone does not identify:
- the specific tablet manufacturer on US packaging (NDC label)
- the specific API suppliers (AMP sulfate) used at a given time
- which entities supply each strength (if different sites are used across SKUs)
Why incomplete supplier identification breaks diligence
For investment and patent landscape work, a supplier list must be tied to source evidence that supports:
- which site manufactured the marketed product (and thus which regulatory history and process controls apply)
- whether API changes occurred across application/label revisions
- whether there are multiple approved drug product sites for the same branded NDCs
A generic statement like “there are multiple suppliers” does not support freedom-to-operate analysis, process IP attribution, or supply-risk mapping.
Key Takeaways
- EVEKEO supplier identification requires source-level confirmation of the labeled drug product manufacturer and, where possible, the API source for amphetamine sulfate.
- A supplier list cannot be produced accurately from the drug name alone.
FAQs
-
Is EVEKEO’s API supplied by a single manufacturer?
Not necessarily; API sourcing can vary by supply agreements and time.
-
Who is the correct “finished dosage” supplier to use for diligence?
The entity listed as the drug product manufacturer on the US package/NDC label for the specific strength.
-
Can EVEKEO suppliers be inferred from the API name only?
No; the API name does not map to specific API vendors used for a given branded SKU.
-
Do EVEKEO strengths always come from the same manufacturing site?
Not always; different strengths can use different sites under the same brand.
-
What is the most reliable evidence type for supplier identification?
Current US labeling and regulatory listings tied to the exact NDC/strength, plus any official documentation that names API and manufacturing sites.
References
[1] FDA. Drug Labeling (EVEKEO) database and package label content, including NDC-linked manufacturer information.
